Top Tech Companies (2,070)
Don't see your company?
Create a company profile
Imagion Biosystems is a Biotechnology Company.
Dialectic Therapeutics is a biotechnology company which is created for innovative technologies to cure cancer.
Crystalplex provides fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets.
Material and Machines Corporation is a developer of comprehensive solutions for science, medicine and agriculture.
Dynatronics is a medical device company committed to providing high-quality restorative products designed to accelerate one to their optimal health. The company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The company is headquartered in greater Salt Lake City, Utah, and its products are marketed under a portfolio of brands including Bird & Cronin®, Dynatron Solaris®, Hausmann, Physician’s Choice®, and PROTEAM™. More information is available at www.dynatronics.com.
We are on a mission to be the leader in adult stem cell research and therapies by developing and distributing FDA approved therapies that are safe, ethical, and affordable; by developing technologies that allow you to safely and affordable bank your own stem cells; by setting industry standards for quality processing and testing of stem cell therapeutics.
AlivaMab Discovery Services is a leader in the discovery of antibody therapeutics, trusted by top-tier pharmaceutical and biotechnology companies to deliver panels of drug-quality human antibodies. We meet our partners' design goals, from simple to extraordinarily challenging, through rapid generation of large, molecularly diverse panels of antibodies with deep functional and kinetic characterization, developability assessment and state of the art engineering approaches. Combining collaborative access to our scientists' creativity and experience with the use of trusted, proven technologies, AlivaMab Discovery Services provides the fastest and most de-risked path through discovery and development.
C16 Biosciences uses innovative processes found in nature to brew sustainable alternatives to palm oil. Palm oil is everywhere: it’s in our food, clothes, shampoo, and even the fuel that powers our cars. But this $61 billion industry has drastic environmental and societal costs: rainforests from Costa Rica to Indonesia are destroyed to make way for oil palm tree plantations, releasing carbon dioxide into the atmosphere and destroying habitats for people and endangered wildlife along the way. But palm oil doesn't have to be a problem. There remains an urgent need for consumers and companies alike to switch to environmentally conscious, sustainable palm oil products. C16 was founded with the objective of creating a sustainable, environmentally friendly alternative to conflict palm oil. By offering producers, refiners, traders and consumers of palm oil an opportunity to invest part of their production into bio-based oils and sustainability efforts, our aim is to reduce the environmental footprint of palm oil production and protect precious natural land, wildlife, and resources in the process. We've developed technology to brew a sustainable alternative to palm oil from microbes. Fermentation is a well-proven commercial process that has been used for centuries to convert raw materials into consumable commercial products consumed by billions of people every day. We believe that brewing palm oil like beer is the best and most likely path to developing a truly sustainable palm oil alternative. Our palm oil is sustainable -- it doesn't involve deforestation, endangering precious animal species, or forcing inhumane labor practices. The result is a world where consumers can enjoy the products they love without worrying about the dangerous practices involved in making them.
Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, and cGMP facilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK.
NuPulse is a medical device company developing novel technology to treat patients with heart failure.
A Biomedical research organization
Grenova™ is an innovative company that is revolutionizing lab consumables through high-quality waste reduction solutions. Our mission is to lower costs in the laboratory industry and reduce biohazard waste in the environment by delivering groundbreaking approaches in dealing with plastic consumables. Every year, over 5 million pounds of plastic pipette tips are disposed of in landfills globally after a single use. This drives significant environmental pollution and unnecessary costs. The typical laboratory consumes several thousand pipette tips every day for samples and assay procedures, due to the lack of options for safely cleaning plastic consumables. Such high consumption of plastic tips adds $25,000 to $1.5 million in annual operational costs for laboratories worldwide. At Grenova™, we know that high consumption of plastic tips is an excessive, avoidable operational cost for companies and a significant contributor to environmental pollution. This is why we decided to create devices that enable labs to wash and recycle pipette tips in large quantities. Grenova devices offer labs the option to reuse plastic tips several times, cutting associated costs by up to 90%. Grenova devices are safe for both the user and the environment, without producing hazardous waste or gases. visit us at: www.grenovasolutions.com
Orgenesis is a pioneering global biotech company featuring a unique Cell & Gene Therapy Biotech Platform. The company is focused on unlocking the power of cell and gene therapies with this platform to provide life changing treatments at the Point of Care (POCare) to large numbers of patients at drastically reduced costs. The Platform consists of a pipeline of POCare Therapeutics; a suite of hand-selected and customized POCare Technologies for closed processing; and a collaborative, global POCare Network of leading companies, research institutes and hospitals. Working with this Platform, Orgenesis leverages cutting edge science to create a more efficient, scalable, and affordable pathway to patients.
Histogen is a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body.
Twenty years ago, we pioneered the world's first clear aligners. Since then, we have continuously innovated with new products and technologies that are revolutionizing treatments for doctors and their patients. Invisalign clear aligners and the iTero Intraoral scanner help dental professionals achieve the clinical results they expect and deliver effective, advanced dental options to their patients. Helping change millions of lives, one smile at a time. Discover your straight path to a bright future at Align. As a part of our smart, diverse and fast-moving global team, you'll make an impact for the market leader that's moving an industry forward. Want to find out what’s next for us—and for you?
Enabling the next generation of breakthroughs in treating human disease.
TNG Pharmaceuticals, a Louisville, KY based company is focused on the research and development of our patented vaccine, FlyVax.
Information Management Services, Inc. (IMS) has 45 plus years of information technology and clinical trials experience. We currently employ a team of 250 computer and biomedical professionals dedicated to providing clients with quality customer support. We offer premium services at competitive prices. In addition, IMS services are available under the following government funding mechanisms:
ECHORD++ aims at strengthening the knowledge transfer between scientific research
At Rare Disease Research, we aim to optimize the process of conducting clinical trials in rare disease conditions. To improve access to investigational therapies, increase opportunities for trial participation, patient recruitment and retention, we have an experienced team with a multidisciplinary approach to orchestrate clinical research trials in rare disease conditions. We closely collaborate with sponsors, CRO, and patient advocacy groups to improve awareness and recruitment for cutting edge clinical trials. Because rare diseases are not often considered a public health matter, we tirelessly advocate for newborn screenings. We want to improve health outcome for infants with rare genetics conditions who otherwise would have to endure diagnosis odyssey and delayed treatment. Our newborn screening project for Spinal Muscular Atrophy will begin in 2018.
